US Stock MarketDetailed Quotes

PHBI PHARMAGREEN BIOTECH INC

Watchlist

0.002
+0.000+5.56%

15min DelayClose Nov 22 16:00 ET

1.26MMarket Cap-1900P/E (TTM)

PHARMAGREEN BIOTECH INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

(Q3)Jun 30, 2022

(Q2)Mar 31, 2022

(Q1)Dec 31, 2021

(FY)Sep 30, 2021

(Q4)Sep 30, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

105.78%7.51K

38.58%-34.27K

86.87%-19.5K

-106.99%-426.57K

-68.22%-92.26K

-184.49%-129.99K

44.85%-55.79K

-3,291.10%-148.53K

66.08%-206.08K

10.21%-54.84K

Net income from continuing operations

-164.67%-162.93K

81.85%-187.98K

-310.29%-39.37K

80.68%-875.51K

86.72%-110.42K

277.13%251.94K

67.03%-1.04M

104.49%18.72K

-82.56%-4.53M

8.85%-831.45K

Operating gains losses

111.92%60.82K

-96.96%17.15K

31.30%-160.95K

-107.14%-215.62K

-106.41%-35.2K

-402.93%-510.07K

-76.15%563.92K

-213.24%-234.27K

155.31%3.02M

370.71%549.29K

Other non cash items

111.24%12.44K

-90.17%42.46K

4,752.20%87.29K

-69.79%421.88K

-80.47%98.94K

-183.42%-110.76K

-36.82%431.9K

-97.56%1.8K

257.66%1.4M

-9.57%506.55K

Change In working capital

-59.32%97.18K

693.40%94.11K

43.41%93.54K

370.57%242.68K

83.68%-45.58K

266.48%238.9K

-104.25%-15.86K

-50.63%65.22K

32.39%-89.69K

-571.18%-279.23K

-Change in receivables

84.96%-37

-1,200.00%-104

-135.96%-82

-1,960.00%-93

66.83%-67

-242.20%-246

98.28%-8

-54.22%228

-99.95%5

-140.81%-202

-Change in inventory

--296

----

--0

----

-Change in prepaid assets

-91.83%20.35K

159.60%40.75K

5,131.02%14.33K

142.74%146.92K

90.22%-33.98K

--249K

-1,921.36%-68.37K

--274

-149.27%-343.74K

-451.36%-347.49K

-Change in payables and accrued expense

876.76%76.57K

19.97%63.01K

22.50%79.28K

-62.27%95.85K

-116.85%-11.54K

-115.16%-9.86K

575.10%52.52K

-50.83%64.72K

5,077.29%254.04K

270.59%68.46K

Cash from discontinued investing activities

Operating cash flow

105.78%7.51K

38.58%-34.27K

86.87%-19.5K

-106.99%-426.57K

-68.22%-92.26K

-184.49%-129.99K

44.85%-55.79K

-3,291.10%-148.53K

66.08%-206.08K

10.21%-54.84K

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-84.36%17.69K

-70.84%18.84K

-65.11%47.43K

21.83%313.71K

78.18%113.14K

-32.86%64.61K

124.15%135.96K

-54.23%257.5K

16.05%37.12K

Net issuance payments of debt

-60.37%17.69K

-50.56%18.84K

7.90%47.43K

1,337.62%126.71K

--0

--44.64K

--38.11K

30.65%43.96K

-101.94%-10.24K

-447.46%-43.88K

Net common stock issuance

--0

-30.15%187K

--0

7.87%68.5K

-72.46%26.5K

240.74%92K

569.32%267.73K

102.50%81K

Net preferred stock issuance

----

--0

----

--10

--0

Cash from discontinued financing activities

Financing cash flow

-84.36%17.69K

-70.84%18.84K

-65.11%47.43K

21.83%313.71K

--0

78.18%113.14K

-32.86%64.61K

124.15%135.96K

-54.23%257.5K

16.05%37.12K

Net cash flow

Beginning cash position

142.56%7.39K

138.34%24.96K

-68.32%8.02K

107.45%25.3K

26.25%24.26K

-77.47%3.05K

-64.81%10.47K

107.45%25.3K

-80.54%12.2K

-44.43%19.22K

Current changes in cash

249.59%25.2K

-274.91%-15.43K

322.19%27.93K

-319.50%-112.86K

-420.44%-92.26K

-194.62%-16.85K

278.56%8.82K

-122.34%-12.57K

214.22%51.42K

39.08%-17.73K

Effect of exchange rate changes

-171.65%-27.28K

86.75%-2.15K

-387.05%-10.98K

349.46%95.58K

219.26%76.01K

414.49%38.07K

-43.66%-16.25K

94.17%-2.26K

-600.16%-38.31K

254.72%23.81K

End cash Position

-78.09%5.32K

142.56%7.39K

138.34%24.96K

-68.32%8.02K

26.25%24.26K

-77.47%3.05K

-64.81%10.47K

107.45%25.3K

Free cash flow

105.78%7.51K

38.58%-34.27K

86.87%-19.5K

-106.99%-426.57K

-68.22%-92.26K

-184.49%-129.99K

44.85%-55.79K

-3,291.10%-148.53K

66.08%-206.08K

10.21%-54.84K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022	(Q3)Jun 30, 2022	(Q2)Mar 31, 2022	(Q1)Dec 31, 2021	(FY)Sep 30, 2021	(Q4)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	105.78%7.51K	38.58%-34.27K	86.87%-19.5K	-106.99%-426.57K	-68.22%-92.26K	-184.49%-129.99K	44.85%-55.79K	-3,291.10%-148.53K	66.08%-206.08K	10.21%-54.84K
Net income from continuing operations	-164.67%-162.93K	81.85%-187.98K	-310.29%-39.37K	80.68%-875.51K	86.72%-110.42K	277.13%251.94K	67.03%-1.04M	104.49%18.72K	-82.56%-4.53M	8.85%-831.45K
Operating gains losses	111.92%60.82K	-96.96%17.15K	31.30%-160.95K	-107.14%-215.62K	-106.41%-35.2K	-402.93%-510.07K	-76.15%563.92K	-213.24%-234.27K	155.31%3.02M	370.71%549.29K
Other non cash items	111.24%12.44K	-90.17%42.46K	4,752.20%87.29K	-69.79%421.88K	-80.47%98.94K	-183.42%-110.76K	-36.82%431.9K	-97.56%1.8K	257.66%1.4M	-9.57%506.55K
Change In working capital	-59.32%97.18K	693.40%94.11K	43.41%93.54K	370.57%242.68K	83.68%-45.58K	266.48%238.9K	-104.25%-15.86K	-50.63%65.22K	32.39%-89.69K	-571.18%-279.23K
-Change in receivables	84.96%-37	-1,200.00%-104	-135.96%-82	-1,960.00%-93	66.83%-67	-242.20%-246	98.28%-8	-54.22%228	-99.95%5	-140.81%-202
-Change in inventory	--296	----	----	----	----	--0	----	----	----	----
-Change in prepaid assets	-91.83%20.35K	159.60%40.75K	5,131.02%14.33K	142.74%146.92K	90.22%-33.98K	--249K	-1,921.36%-68.37K	--274	-149.27%-343.74K	-451.36%-347.49K
-Change in payables and accrued expense	876.76%76.57K	19.97%63.01K	22.50%79.28K	-62.27%95.85K	-116.85%-11.54K	-115.16%-9.86K	575.10%52.52K	-50.83%64.72K	5,077.29%254.04K	270.59%68.46K
Cash from discontinued investing activities
Operating cash flow	105.78%7.51K	38.58%-34.27K	86.87%-19.5K	-106.99%-426.57K	-68.22%-92.26K	-184.49%-129.99K	44.85%-55.79K	-3,291.10%-148.53K	66.08%-206.08K	10.21%-54.84K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-84.36%17.69K	-70.84%18.84K	-65.11%47.43K	21.83%313.71K	0	78.18%113.14K	-32.86%64.61K	124.15%135.96K	-54.23%257.5K	16.05%37.12K
Net issuance payments of debt	-60.37%17.69K	-50.56%18.84K	7.90%47.43K	1,337.62%126.71K	--0	--44.64K	--38.11K	30.65%43.96K	-101.94%-10.24K	-447.46%-43.88K
Net common stock issuance	--0	--0	--0	-30.15%187K	--0	7.87%68.5K	-72.46%26.5K	240.74%92K	569.32%267.73K	102.50%81K
Net preferred stock issuance	----	----	----	--0	----	----	----	----	--10	--0
Cash from discontinued financing activities
Financing cash flow	-84.36%17.69K	-70.84%18.84K	-65.11%47.43K	21.83%313.71K	--0	78.18%113.14K	-32.86%64.61K	124.15%135.96K	-54.23%257.5K	16.05%37.12K
Net cash flow
Beginning cash position	142.56%7.39K	138.34%24.96K	-68.32%8.02K	107.45%25.3K	26.25%24.26K	-77.47%3.05K	-64.81%10.47K	107.45%25.3K	-80.54%12.2K	-44.43%19.22K
Current changes in cash	249.59%25.2K	-274.91%-15.43K	322.19%27.93K	-319.50%-112.86K	-420.44%-92.26K	-194.62%-16.85K	278.56%8.82K	-122.34%-12.57K	214.22%51.42K	39.08%-17.73K
Effect of exchange rate changes	-171.65%-27.28K	86.75%-2.15K	-387.05%-10.98K	349.46%95.58K	219.26%76.01K	414.49%38.07K	-43.66%-16.25K	94.17%-2.26K	-600.16%-38.31K	254.72%23.81K
End cash Position	-78.09%5.32K	142.56%7.39K	138.34%24.96K	-68.32%8.02K	-68.32%8.02K	26.25%24.26K	-77.47%3.05K	-64.81%10.47K	107.45%25.3K	107.45%25.3K
Free cash flow	105.78%7.51K	38.58%-34.27K	86.87%-19.5K	-106.99%-426.57K	-68.22%-92.26K	-184.49%-129.99K	44.85%-55.79K	-3,291.10%-148.53K	66.08%-206.08K	10.21%-54.84K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data